{
  "url": "https://openlegislation.uk/eu-regulation-2008-1272/annex-I/division-3/division-3.4/division-3.4.2/division-3.4.2.1/division-3.4.2.1.1/division-3.4.2.1.1.4",
  "json_url": "https://openlegislation.uk/eu-regulation-2008-1272/annex-I/division-3/division-3.4/division-3.4.2/division-3.4.2.1/division-3.4.2.1.1/division-3.4.2.1.1.4.json",
  "legislation": "eur/2008/1272",
  "legislation_title": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2008-1272",
  "path": "annex/I/division/3/division/3.4/division/3.4.2/division/3.4.2.1/division/3.4.2.1.1/division/3.4.2.1.1.4",
  "kind": "division",
  "number": "3.4.2.1.1.4",
  "heading": null,
  "text": "Substances shall be classified as respiratory sensitisers in accordance with the criteria in Table 3.4.1:\nTable 3.4.1\nHazard category and sub-categories for respiratory sensitisers\nAt present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment.\nCategory\nCriteria\nCategory 1\nSubstances shall be classified as respiratory sensitisers (Category 1) where data are not sufficient for sub-categorisation in accordance with the following criteria:\n(a) if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity; and/or\n(b) if there are positive results from an appropriate animal test.\nSub-category 1A:\nSubstances showing a high frequency of occurrence in humans; or a probability of occurrence of a high sensitisation rate in humans based on animal or other tests . Severity of reaction may also be considered.\nSub-category 1B:\nSubstances showing a low to moderate frequency of occurrence in humans; or a probability of occurrence of a low to moderate sensitisation rate in humans based on animal or other tests . Severity of reaction may also be considered.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Substituted by Commission Regulation (EU) No 286/2011 of 10 March 2011 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)."
    },
    {
      "type": "footnote",
      "label": "f1",
      "text": "At present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2008/1272/annex/I/division/3/division/3.4/division/3.4.2/division/3.4.2.1/division/3.4.2.1.1/division/3.4.2.1.1.4",
    "retrieved_at": "2026-11-01T14:51:47.470832+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}